TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/10/2025
Back to search
Official data from USPTO
OXULAR
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000090737118Class
5, 9, 10, 41, 42
Filing
90737118
Registration
7342091
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
47
Latest update
03/15/2025
Trademark type
Combined
Nice classes
5, 9, 10, 41, 42
Filing date
05/26/2021
Registration date
04/02/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/02/2024
Last transaction
03/15/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
3
Owner type
99
Owner location
Oxford, GB
Examiner
SOUDERS, MICHAEL
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "OXULAR" with a triangle pointed down coming through the top and stopping in the middle of the "O" and with a circle in the middle of the "O". The letters "O" and "X" are the color blue. The letters "ULAR" are green. The triangle design and circle are green. The white represents background and/or transparent areas and is not part of the mark.
Holders and representatives
Holders
Oxular Limited
Representatives
Jeffrey J. Scepanski Ruggiero McAllister & McMahon LLC
Technical classification
Nice Classes
Class 5Class 9Class 10Class 41Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of ophthalmological and retinal diseases and conditions; ophthalmic preparations; pharmaceutical and ophthalmic preparations and substances for the prevention and treatment of retinal diseases and disorders
Class 9
Downloadable computer software to assess the architecture and depth of targeted eye tissue to enable precise delivery of medical products into the eye; downloadable computer software for collectingtransmittingsharingreceivingstreamingdownloadingplayingorganizingdisplayingcollecting and transferring informationdatavideoimagescontent and other content for medicinal and research use; downloadable webinars in the field of ophthalmology
Class 10
medical instruments and apparatus for administering pharmaceutical and ophthalmic preparations and substances; medical instruments and apparatus for administering pharmaceutical and ophthalmic preparations and substances for the prevention and treatment of ophthalmological and retinal diseases and disorders; software embedded in medical instruments and apparatus for administering pharmacological and ophthalmic preparations and substances for the prevention and treatment pf ophthalmological and retinal diseases and disorders
Class 41
Education servicesproviding classesseminarsworkshopsproviding non-downloadable webinars in the field of ophthalmology; training services in the field of ophthalmology; providing online electronic non-downloadable publications in the nature of medical and trade journals in the field of ophthalmology; providing online non-downloadable videos in the field of ophthalmology
Class 42
Scientific and technological servicesscientific researchanalysistesting in the field of ophthalmology; researchdevelopment and testing in the fields of pharmaceutical and ophthalmic preparations and substances; researchdevelopment and testing in the field of medical instruments and apparatus; researchdevelopment and testing in the fields of retinal therapeuticsdiseases and disorders; medical and scientific researchconducting clinical trials for pharmaceutical and ophthalmic preparations and substances for others; medical and scientific researchconducting clinical trials for retinal therapeuticsdiseases and disorders for others; advisory and consulting services related to scientific and technological servicesscientific clinical trials for others and information technology
Publications
History of USPTO decisions and trademark events.
47 publications found
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
03/10/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/10/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/10/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/02/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
04/02/2024
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
02/27/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/27/2024
IUCN
NOTICE OF ALLOWANCE CANCELLED
01/02/2024
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
01/02/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/12/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/17/2023
PUBO
PUBLISHED FOR OPPOSITION
10/17/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/27/2023
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
09/11/2023
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
09/08/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/05/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/01/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/01/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
09/01/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
06/16/2023
GNFR
FINAL REFUSAL E-MAILED
06/16/2023
CNFR
FINAL REFUSAL WRITTEN
06/16/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/05/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/05/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
06/02/2023
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
04/14/2023
GNSI
INQUIRY TO SUSPENSION E-MAILED
04/14/2023
CNSI
SUSPENSION INQUIRY WRITTEN
04/14/2023
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
04/14/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
10/04/2022
GNSL
LETTER OF SUSPENSION E-MAILED
10/04/2022
CNSL
SUSPENSION LETTER WRITTEN
10/04/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/14/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/14/2022
ALIE
ASSIGNED TO LIE
09/12/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/08/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/09/2022
GNRT
NON-FINAL ACTION E-MAILED
02/09/2022
CNRT
NON-FINAL ACTION WRITTEN
02/09/2022
DOCK
ASSIGNED TO EXAMINER
02/08/2022
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
08/21/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/20/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/20/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/20/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/20/2021
NWAP
NEW APPLICATION ENTERED
05/29/2021
Continuous trademark protection
Get notified about every new filing that threatens OXULAR or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.